SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Jun 10, 2016
Document Date
Jun 10, 2016
Form Description
Tender offer schedule and amendment filed by a third party.
Filing Group
Mergers & Acquisitions
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC